BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26889320)

  • 1. Seven year review of retention in HIV care and treatment in federal medical centre Ido-Ekiti.
    Babatunde O; Ojo OJ; Atoyebi OA; Ekpo DS; Ogundana AO; Olaniyan TO; Owoade JA
    Pan Afr Med J; 2015; 22():139. PubMed ID: 26889320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of Patient Retention in HIV Care and Treatment Programs in Nigeria.
    Ugoji C; Okere N; Dakum P; Ake-Uzoigwe R; Igboelina D; Ndembi N; Ekong E; Charurat M; Blattner WA
    Curr HIV Res; 2015; 13(4):300-7. PubMed ID: 25777516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of linkage and retention in HIV care continuum among patients attending referral HIV care clinic in private sector in India.
    Parchure R; Kulkarni V; Kulkarni S; Gangakhedkar R
    AIDS Care; 2015; 27(6):716-22. PubMed ID: 25559639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitators and barriers for retention in HIV care between testing and treatment in Asia-A study in Bangladesh, Indonesia, Lao, Nepal, Pakistan, Philippines and Vietnam.
    Koirala S; Deuba K; Nampaisan O; Marrone G; Ekström AM;
    PLoS One; 2017; 12(5):e0176914. PubMed ID: 28459881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How are children with HIV faring in Nigeria?--a 7 year retrospective study of children enrolled in HIV care.
    Ojeniran MA; Emokpae A; Mabogunje C; Akintan P; Hoshen M; Weiss R
    BMC Pediatr; 2015 Jul; 15():87. PubMed ID: 26198439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa.
    Clouse K; Pettifor AE; Maskew M; Bassett J; Van Rie A; Behets F; Gay C; Sanne I; Fox MP
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):e39-46. PubMed ID: 23011400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T-lymphocytes cell counts in adults with human immunodeficiency virus infection at the medical department of a tertiary health institution in Nigeria.
    Ajayi AO; Ajayi EA; Fasakin KA
    Ann Afr Med; 2009; 8(4):257-60. PubMed ID: 20139549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study.
    Okoboi S; Ssali L; Yansaneh AI; Bakanda C; Birungi J; Nantume S; Okullu JL; Sharp AR; Moore DM; Kalibala S
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20841. PubMed ID: 27443271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.
    Nsanzimana S; Remera E; Kanters S; Forrest JI; Ford N; Condo J; Binagwaho A; Bucher H; Thorlund K; Vitoria M; Mills EJ
    Lancet HIV; 2015 Sep; 2(9):e376-84. PubMed ID: 26423551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing community linkage to care and antiretroviral therapy Initiation: Lessons from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) and their adaptation in Nigeria ART Surge.
    Jahun I; Said I; El-Imam I; Ehoche A; Dalhatu I; Yakubu A; Greby S; Bronson M; Brown K; Bamidele M; Boyd AT; Bachanas P; Dirlikov E; Agbakwuru C; Abutu A; Williams-Sherlock M; Onotu D; Odafe S; Williams DB; Bassey O; Ogbanufe O; Onyenuobi C; Adeola A; Meribe C; Efuntoye T; Fagbamigbe OJ; Fagbemi A; Ene U; Nguhemen T; Mgbakor I; Alagi M; Asaolu O; Oladipo A; Amafah J; Nzelu C; Dakum P; Mensah C; Aliyu A; Okonkwo P; Oyeledun B; Oko J; Ikpeazu A; Gambo A; Charurat M; Ellerbrock T; Aliyu S; Swaminathan M
    PLoS One; 2021; 16(9):e0257476. PubMed ID: 34543306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention in Care of Adult HIV Patients Initiating Antiretroviral Therapy in Tigray, Ethiopia: A Prospective Observational Cohort Study.
    Bucciardini R; Fragola V; Abegaz T; Lucattini S; Halifom A; Tadesse E; Berhe M; Pugliese K; Binelli A; De Castro P; Terlizzi R; Fucili L; Di Gregorio M; Mirra M; Olivieri E; Teklu T; Zegeye T; Haile A; Vella S; Abraham L; Godefay H;
    PLoS One; 2015; 10(9):e0136117. PubMed ID: 26340271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in CD4 Count Testing, Retention in Pre-ART Care, and ART Initiation Rates over the First Decade of Expansion of HIV Services in Haiti.
    Koenig SP; Bernard D; Dévieux JG; Atwood S; McNairy ML; Severe P; Marcelin A; Julma P; Apollon A; Pape JW
    PLoS One; 2016; 11(2):e0146903. PubMed ID: 26901795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion and scale-up of HIV care and treatment services in four countries over ten years.
    Teasdale CA; Abrams EJ; Yuengling KA; Lamb MR; Wang C; Vitale M; Hawken M; Melaku Z; Nuwagaba-Biribonwoha H; El-Sadr WM
    PLoS One; 2020; 15(4):e0231667. PubMed ID: 32298331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy programme outcomes at Senkatana antiretroviral therapy clinic, Lesotho: a four-year retrospective cohort study.
    Kabuya M; Musekiwa A; Takuva S; Thabane L; Mbuagbaw L
    Pan Afr Med J; 2023; 46():74. PubMed ID: 38282767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline CD4+ T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria.
    Adekunle AE; Oladimeji AA; Temi AP; Adeseye AI; Akinyeye OA; Taiwo RH
    Pan Afr Med J; 2011; 9():6. PubMed ID: 22145054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
    AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a youth-friendly HIV clinic: 10 years of adolescent outcomes in Port-au-Prince, Haiti.
    Reif LK; Bertrand R; Benedict C; Lamb MR; Rouzier V; Verdier R; Johnson WD; Pape JW; Fitzgerald DW; Kuhn L; McNairy ML
    J Int AIDS Soc; 2016; 19(1):20859. PubMed ID: 27389256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV care continuum in Rwanda: a cross-sectional analysis of the national programme.
    Nsanzimana S; Kanters S; Remera E; Forrest JI; Binagwaho A; Condo J; Mills EJ
    Lancet HIV; 2015 May; 2(5):e208-15. PubMed ID: 26423003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.